FACTORS ASSOCIATED WITH THE OUTCOME OF LAMOTRIGINE TREATMENT IN JUVENILE MYOCLONIC EPILEPSY

被引:0
|
作者
Bodenstein, H. [1 ]
Gandelman-Marton, R. [2 ]
Gidoni-Ben-Zeev, B. [1 ]
Blatt, I. [1 ]
机构
[1] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
[2] Assaf Harofeh Med Ctr, Zerifin, Israel
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:191 / 191
页数:1
相关论文
共 50 条
  • [1] Outcome of lamotrigine treatment in juvenile myoclonic epilepsy
    Bodenstein-Sachar, H.
    Gandelman-Marton, R.
    Ben-Zeev, B.
    Chapman, J.
    Blatt, I.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2011, 124 (01): : 22 - 27
  • [2] Lamotrigine for the treatment of juvenile myoclonic epilepsy.
    Sokic, DV
    Pavlovic, Z
    Jankovic, SM
    Levic, Z
    [J]. EPILEPSIA, 1999, 40 : 38 - 38
  • [3] The use of lamotrigine in juvenile myoclonic epilepsy
    Buchanan, N
    [J]. SEIZURE, 1996, 5 (02) : 149 - 151
  • [4] Exacerbation of juvenile myoclonic epilepsy with lamotrigine
    Biraben, A
    Allain, H
    Scarabin, JM
    Schück, S
    Edan, G
    [J]. NEUROLOGY, 2000, 55 (11) : 1758 - 1758
  • [5] Lamotrigine Monotherapy in Juvenile Myoclonic Epilepsy
    Kim, J.
    Choi, S-W.
    Sohn, M-J.
    [J]. EPILEPSIA, 2018, 59 : S276 - S276
  • [6] Efficacy of lamotrigine in children with juvenile myoclonic epilepsy
    Mandelbaum, DE
    Venkatasubramanian, A
    Kugler, SL
    [J]. EPILEPSIA, 1999, 40 : 133 - 134
  • [7] Lamotrigine as first choice drug in juvenile myoclonic epilepsy treatment.
    Carignani, M
    [J]. EPILEPSIA, 1999, 40 : 283 - 283
  • [8] Lamotrigine (LTG) in the treatment of pregnant patients with juvenile myoclonic epilepsy.
    Jovic, NJ
    [J]. EPILEPSIA, 1999, 40 : 211 - 211
  • [9] Lamotrigine (LTG) in the treatment of pregnant patients with juvenile myoclonic epilepsy.
    Jovic, NJ
    [J]. EPILEPSIA, 1999, 40 : 283 - 283
  • [10] Predictors of Outcome in Juvenile Myoclonic Epilepsy
    Chen, Yiqian
    Chen, Jingzhen
    Chen, Xingyu
    Wang, Ru
    Zeng, Jianqi
    Wang, Feng
    Miao, Jiayin
    [J]. RISK MANAGEMENT AND HEALTHCARE POLICY, 2020, 13 : 609 - 613